Berbamine derivatives: A novel class of compounds for anti-leukemia activity

European Journal of Medicinal Chemistry

Volumn 44, Issue 8, 2009, Pages 3293-3298

  Xie, Jinwen ^a   Ma, Ting ^a   Gu, Ying ^b,c   Zhang, Xuzhao ^b,c   Qiu, Xi ^b,c   Zhang, Lei ^b,c   Xu, Rongzhen ^b,c   Yu, Yongping ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Anti leukemia activity; Berbamine derivatives; Bisbenzylisoquinoline alkaloid

Indexed keywords

BERBAMINE; BISBENZYLISOQUINOLINE ALKALOID; IMATINIB; O (1H INDOLE 2 CARBONYL)BERBAMINE; O (2 METHYLBENZOYL)BERBAMINE; O (4 NITROBENZYL)BERBAMINE; O [(6 CHLOROPYRIDIN 3 YL)METHYL]BERBAMINE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BERBERIS; CELL CYCLE; CELL STRAIN K 562; CHINESE HERB; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZYLISOQUINOLINES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA; PIPERAZINES; PYRIMIDINES;

EID: 67349250886     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.02.018     Document Type: Article

References (23)

1. Angerhofer C.K., Guinaudeau H., Wongpanich V., Pezzuto J.M., and Cordell G.A. J. Nat. Prod. 62 (1999) 59-66
2. Luo C., Lin X., Li W., Yang X., Wang L., Xie S., and Xiao P. Phytother. Res. 11 (1997) 585-587
3. Shiraishi N., Akiyama S., Nakagawa M., Kobayashi M., and Kuwano M. Cancer Res. 47 (1987) 2413-2416
4. Matsuno T., Orita K., Edashige K., Kobuchi H., Sato E.F., Inouye B., Inoue M., and Utsumi K. Biochem. Pharmacol. 39 (1990) 1255-1259
5. Ju H., Li X., Zhao B., Han Z., and Xin W. Biochem. Pharmacol. 39 (1990) 1673-1678
6. Akiba S., Nagatomo R., Ishimoto T., and Sato T. Eur. J. Pharmacol 291 (1995) 343-350
7. Kanako S., Fumiko N., Minoru O., and Naoto A. Biochem. Pharmacol. 66 (2003) 379-385
8. Karin M., Frank S., Dietmar S., and Michael W. Planta Med. 67 (2001) 623-627
9. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., and Sawyers C.L. N. Engl. J. Med. 344 (2001) 1031-1037
10. le Coutre P., Tassi E., Varella-Garcia M., Barni R., Mologni L., Cabrita G., Marchesi E., Supino R., and Gambacorti-Passerini C. Blood 95 (2000) 1758-1766
11. Xu R., Dong Q., Yu Y., Zhao X., Gan X., Wu D., Lu Q., Xu X., and Yu X. Leuk. Res. 30 (2006) 17-23
12. Zhao X., He Z., Wu D., and Xu R. Chin. Med. J. 120 (2007) 802-806
13. Liu J., Qi S., Zhu H., Zhang J., Li Z., and Wang T. Chin. Med. J. 115 (2002) 759-762
14. Xu Y., and Zhang S. Biochem. Biophys. Res. Commun. 140 (1986) 461-467
15. Hu Z., Gong Y., and Huang W. Biochem. Pharmacol. 44 (1992) 1543-1547
16. Zhu H., Wang J., Guo Q., Jiang Y., and Liu G. Biol. Pharm. Bull. 28 (2005) 1974-1978
17. Samanta A.K., Lin H., Sun T., Kantarjian H., and Arlinghaus R.B. Cancer Res. 66 (2006) 6468-6472
18. Mukhopadhyay A., Shishodia S., Suttles J., Brittingham K., Lamothe B., Nimmanapalli R., Bhalla K.N., and Aggarwal B.B. J. Biol. Chem. 277 (2002) 30622-30628
19. Kirchner D., Duyster J., Ottmann O., Schmid R.M., Bergmann L., and Munzert G. Exp. Hematol. 31 (2003) 504-511
20. Braun T., Carvalho G., Coquelle A., Vozenin M.C., Lepelley P., Hirsch F., Kiladjian J.J., Ribrag V., Fenaux P., and Kroemer G. Blood 107 (2006) 1156-1165
21. Vilimas T., Mascarenhas J., Palomero T., Mandal M., Buonamici S., Meng F., Thompson B., Spaulding C., Macaroun S., Alegre M.L., Kee B.L., Ferrando A., Miele L., and Aifantis I. Nat. Med. 13 (2007) 70-77
22. Guzman M.L., Neering S.J., Upchurch D., Grimes B., Howard D.S., Rizzieri D.A., Luger S.M., and Jordan C.T. Blood 98 (2001) 2301-2307
23. Holtz M.S., Forman S.J., and Bhatia R. Leukemia 19 (2005) 1034-1041